CC(C)CON=C1CC(O)C(O)C2C1CCC1C(=O)N(Cc3ccc4c(c3)OCO4)C(=O)C12
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?